A team of researchers has reported an important advance in the search for better treatments for advanced prostate cancer.

ORLANDO - In a press release on July 1, Orlando Health announced that is now “one of the first health systems in the nation” ...

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate ...

The partnership will evaluate whether imaging- and biomarker-informed insights can support a more personalised approach to ...

Thousands of men with prostate cancer will be offered a more targeted radiotherapy by the NHS which requires just five doses.

Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

Prostate cancer is the most common cancer in men in the UK, with more than 55,000 men being diagnosed every year ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due to its slow growing nature and reduced symptoms. Increased risk factors ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...